Pressure BioSciences, Inc. ( PBIO) - Key Metrics
PBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0.01 | -$0.14 | -$0.01 | -$0.01 |
| 2024Q1 | $0.01 | -$0.20 | -$0.05 | -$0.05 |
| 2023Q4 | $0.01 | -$0.44 | -$0.05 | -$0.38 |
| 2023Q3 | $0.02 | -$0.29 | -$0.03 | -$0.03 |
| 2023Q2 | $0.03 | -$0.36 | -$0.05 | -$0.05 |
PBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | -17763.08% | -0.20 |
| 2024Q1 | 0% | -0.19 |
| 2023Q4 | 0% | -0.19 |
| 2023Q3 | 0% | -0.17 |
| 2023Q2 | 0% | -0.30 |
PBIO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q2 | -11.42% | 20455.80% |
| 2024Q1 | -27.48% | 0% |
| 2023Q4 | -115.95% | 0% |
| 2023Q3 | -17.40% | 0% |
| 2023Q2 | -6.79% | 0% |
PBIO
Price: $0
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.83 USD
P/E Ratio: -0.01
Exchange: OEM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 49100
Ebitda: -3.8 millionMarket Capitalization: 28677